Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls

被引：0
作者：
A Corso
A Dovio
C Rusconi
M L Sartori
C Klersy
M Varettoni
S Mangiacavalli
P Zappasodi
M Ventura
A Angeli
M Lazzarino
机构：
[1] IRCCS Policlinico San Matteo,Dipartimento di Scienze Cliniche e Biologiche
[2] University of Pavia,Division of Hematology
[3] University of Turin,undefined
[4] Biometry and Clinical Epidemiology,undefined
[5] University of Pavia,undefined
来源：
Leukemia | 2004年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1555 / 1557
页数：2
相关论文
共 34 条
[1]  
Sezer O(2003)RANK ligand and osteoprotegerin in myeloma bone disease Blood 101 2094-2098
[2]  
Heider U(2001)Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease Blood 98 2269-2271
[3]  
Zavrski I(2003)Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index Blood 102 1064-1069
[4]  
Kuhne CA(2002)Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells Blood 100 3002-3007
[5]  
Hofbauer LC(2001)Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess – possible role in bone homeostasis Eur J Endocrinol 145 685-690
[6]  
Seidel C(2003)Osteoprotegerin sRANKL serum levels in multiple myeloma patients Haematol J 4 S157-88
[7]  
Hjertner O(2002)The alpha(v)beta3 integrin, NF-kappaB, osteoprotegerin endothelial cell survival pathway. Potential role in angiogenesis Trends Cardiovasc Med 12 83-undefined
[8]  
Abildgaard N(undefined)undefined undefined undefined undefined-undefined
[9]  
Heickendorff L(undefined)undefined undefined undefined undefined-undefined
[10]  
Hjorth M(undefined)undefined undefined undefined undefined-undefined
1234